Forekomsten af disse bivirkninger var også højere hos patienter, der samtidig tog lipidsænkende medicin, sammenlignet med patienter, der ikke gjorde det (0, 58% sammenlignet med 0, 39%).
The incidence of these AEs was also higher in patients taking concomitant lipid lowering medications compared with those who did not (0.58% vs 0.39%).